Clinical Trials Sponsored by ECLEXYS SAGL

Total 118 results

Ergoterapia Manoegomito Sagl

Unknown

EFFECTIVENESS OF GRADED MOTOR IMAGERY TO PREVENT CRPS IN PATIENTS WITH DISTAL RADIUS FRACTURE AFTER SURGERY

Surgery | Distal Radius Fracture | CRPS (Complex Regional Pain Syndromes) | Wrist Fracture
Devintec Sagl
Meditrial SrL

Recruiting

Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation

Recurrent Aphthous Ulcer

Italy
Devintec Sagl
CEBIS International

Recruiting

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C (RELAX)

Irritable Bowel Syndrome With Constipation (IBS-C)

Bulgaria
Sage Therapeutics

Completed

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Tinnitus

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Parkinson Disease | Cognitive Dysfunction

United States
Saga University

Active, not recruiting

Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

Heart Failure

Japan
Sage Therapeutics

Completed

Evaluate SAGE-547 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Completed

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (SRSE)

Super-refractory Status Epilepticus

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Sage Therapeutics

Completed

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

Postpartum Depression

United States
Sage Therapeutics

Completed

A Study With SAGE-547 for Super-Refractory Status Epilepticus

Super-Refractory Status Epilepticus

United States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Serbia, Spain, Sweden, United Kingdom
Sage Therapeutics

Completed

Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression

Postpartum Depression

United States
Sage Therapeutics

Completed

Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants

Healthy Volunteer

United States
Sage Therapeutics

Withdrawn

A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)

Postpartum Depression
Sage Therapeutics

Recruiting

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

Huntington Disease

United States, Canada
Sage Therapeutics

Recruiting

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Huntington's Disease

United States, Australia, Canada, United Kingdom
Sage Therapeutics

Completed

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Huntington Disease

United States
Sage Therapeutics

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Saga University

Active, not recruiting

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) (FIVE-STAR)

Chronic Kidney Diseases | Type 2 Diabetes

Japan
Sage Therapeutics

Completed

A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

Postpartum Depression

United States
Sage Therapeutics

Terminated

A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Sage Therapeutics

Completed

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Severe Postpartum Depression

United States
Sage Therapeutics

Recruiting

A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Active, not recruiting

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease | Mild Dementia

United States, Puerto Rico
Sage Therapeutics

Completed

A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment

Parkinson Disease | Cognitive Dysfunction

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Cognitive Dysfunction | Alzheimer Disease | Mild Dementia

United States
Sage Therapeutics

Completed

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Post Partum Depression

United States
Sage Therapeutics

Completed

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)

Postpartum Depression

United States
Sage Therapeutics

Approved for marketing

Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression

Postpartum Depression
Sage Therapeutics

No longer available

An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Super-Refractory Status Epilepticus
Sage Therapeutics
Biogen

Recruiting

Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Medos International SARL

Recruiting

A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis

Intracranial Atherosclerosis

China
Russell Sage College

Completed

Effectiveness of Music Practical Examinations

Stress | Test Anxiety

United States
GlaxoSmithKline
Sage Analytica

Completed

Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

Respiratory Syncyctial Virus Vaccines
GlaxoSmithKline
Sage Analytica

Completed

Influenza Burden Assessment in the United Kingdom, 1996-2008

Influenza
Sage Therapeutics
Biogen

Active, not recruiting

Study to Evaluate SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics
Biogen

Completed

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Saol Therapeutics Inc

Active, not recruiting

Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity (RAISE)

Spasticity

United States
Saol Therapeutics Inc

Active, not recruiting

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain (COMPASS)

Osteoarthritis, Knee Pain

United States
The Sage Colleges

Completed

Ultrasound Treatment in the Management of Plantar Fasciitis

Plantar Fascitis
The Sage Colleges

Unknown

The Effectiveness of Ultrasound Treatment in the Management of Plantar Fasciitis

Plantar Fascitis

United States
A.T. Resolve SARL

Completed

Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery

Pain | Inflammation | Cataract

United States
GlaxoSmithKline
Sage Analytica

Completed

Influenza Burden Assessment in the United States, July1997 - up to April 2009

Influenza
Nealth Sarl
ROUSSELOT SAS

Completed

Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women

Osteoporosis

France
Nealth Sarl
Roquette Freres

Completed

Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects (ROQ_NUTRIMETAB)

Overweight

France
Nealth Sarl
Roquette Freres

Completed

Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota. (ROQ_NUTRIFLORE)

Microbiota | Dietary Fibers

France
Zimmer Biomet
Biomet France SARL

Terminated

TESS Shoulder Arthroplasty Data Collection

Arthritis

France, Belgium

3

Subscribe